These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
726 related items for PubMed ID: 19445945
1. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Louvet A, Wartel F, Castel H, Dharancy S, Hollebecque A, Canva-Delcambre V, Deltenre P, Mathurin P. Gastroenterology; 2009 Aug; 137(2):541-8. PubMed ID: 19445945 [Abstract] [Full Text] [Related]
2. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis. Spahr L, Garcia I, Bresson-Hadni S, Rubbia-Brandt L, Guler R, Olleros M, Chvatchko Y, Hadengue A. Liver Int; 2004 Dec; 24(6):582-7. PubMed ID: 15566508 [Abstract] [Full Text] [Related]
3. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. Louvet A, Diaz E, Dharancy S, Coevoet H, Texier F, Thévenot T, Deltenre P, Canva V, Plane C, Mathurin P. J Hepatol; 2008 Mar; 48(3):465-70. PubMed ID: 18164508 [Abstract] [Full Text] [Related]
4. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial. Sharma P, Kumar A, Sharma BC, Sarin SK. J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081 [Abstract] [Full Text] [Related]
5. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L, Boleslawski E, Deltenre P, Canva V, Pruvot FR, Mathurin P. Hepatology; 2007 Jun; 45(6):1348-54. PubMed ID: 17518367 [Abstract] [Full Text] [Related]
6. Risk factors for infections in cirrhotic patients with and without hepatocellular carcinoma. Yoneyama K, Miyagishi K, Kiuchi Y, Shibata M, Mitamura K. J Gastroenterol; 2002 Jun; 37(12):1028-34. PubMed ID: 12522534 [Abstract] [Full Text] [Related]
7. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. Stewart S, Prince M, Bassendine M, Hudson M, James O, Jones D, Record C, Day CP. J Hepatol; 2007 Aug; 47(2):277-83. PubMed ID: 17532088 [Abstract] [Full Text] [Related]
8. Is alcoholic hepatitis an indication for transplantation? Current management and outcomes. Mathurin P. Liver Transpl; 2005 Nov; (11 Suppl 2):S21-4. PubMed ID: 16237730 [Abstract] [Full Text] [Related]
9. Prediction of survival for patients with bullous pemphigoid: a prospective study. Joly P, Benichou J, Lok C, Hellot MF, Saiag P, Tancrede-Bohin E, Sassolas B, Labeille B, Doutre MS, Gorin I, Pauwels C, Chosidow O, Caux F, Estève E, Dutronc Y, Sigal M, Prost C, Maillard H, Guillaume JC, Roujeau JC. Arch Dermatol; 2005 Jun; 141(6):691-8. PubMed ID: 15967914 [Abstract] [Full Text] [Related]
10. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. Phillips M, Curtis H, Portmann B, Donaldson N, Bomford A, O'Grady J. J Hepatol; 2006 Apr; 44(4):784-90. PubMed ID: 16469404 [Abstract] [Full Text] [Related]
12. A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation. Tandon P, Goodman KJ, Ma MM, Wong WW, Mason AL, Meeberg G, Bergsten D, Carbonneau M, Bain VG. Am J Gastroenterol; 2009 Jul; 104(7):1700-6. PubMed ID: 19471253 [Abstract] [Full Text] [Related]
17. Infection does not increase long-term mortality in patients with acute severe alcoholic hepatitis treated with corticosteroids. Dhanda AD, Sinha A, Hunt V, Saleem S, Cramp ME, Collins PL. World J Gastroenterol; 2017 Mar 21; 23(11):2052-2059. PubMed ID: 28373772 [Abstract] [Full Text] [Related]